drugset / Trial / NCT01479127
Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
To explore the safety, tolerability, pharmacokinetics and efficacy of ABT-SLV187 in advanced Parkinson's disease (PD) patients with severe motor complications. The complications of medical devices for the naso-jejunum (NJ) infusion system of ABT-SLV187 will also be investigated.
Timeline
- Start
- 2011-10
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Levodopa | Small molecule | — | Other |
| Background | Carbidopa | Unknown | 10 mg | Oral |
| Background | Levodopa | Small molecule | 100 mg | Oral |